𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ifosfamide in pediatric malignant solid tumors

✍ Scribed by C. B. Pratt; E. C. Douglass; E. L. Etcubanas; M. P. Goren; A. A. Green; F. A. Hayes; M. E. Horowitz; W. H. Meyer; E. I. Thompson; J. A. Wilimas

Publisher
Springer
Year
1989
Tongue
English
Weight
438 KB
Volume
24
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ifosfamide/etoposide combination in the
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study
✍ Faith H. Kung; Charles B. Pratt; Roger A. Vega; Norman Jaffe; Douglas Strother; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

Background. The prognosis for children with recurrent or resistant malignant solid tumors remains dismal. More effective rescue therapy is needed for these children. Methods. Between August 1987 and November 1990, 311 children with recurrent or resistant malignant solid tumors were treated by inves

Aziridinylbenzoquinone (AZQ) in the trea
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors
✍ R. P. Castleberry; A. H. Ragab; C. P. Steuber; B. Kamen; S. Toledano; K. Starlin πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 445 KB

To assess the response rates and toxicity of AZQ in children with recurrent brain and other malignant solid tumors, a phase II study was implemented by the Pediatric Oncology Group. Eligible patients received AZQ 18 mg/M2/week i.v. for 4 doses followed by a 2 week rest period. Each dose was given ov